Development of Store-Operated Calcium Entry-Targeted Compounds in Cancer.

Frontiers in Pharmacology
Xiaojing LiangWeidong Han

Abstract

Store-operated Ca2+ entry (SOCE) is the major pathway of Ca2+ entry in mammalian cells, and regulates a variety of cellular functions including proliferation, motility, apoptosis, and death. Accumulating evidence has indicated that augmented SOCE is related to the generation and development of cancer, including tumor formation, proliferation, angiogenesis, metastasis, and antitumor immunity. Therefore, the development of compounds targeting SOCE has been proposed as a potential and effective strategy for use in cancer therapy. In this review, we summarize the current research on SOCE inhibitors and blockers, discuss their effects and possible mechanisms of action in cancer therapy, and induce a new perspective on the treatment of cancer.

References

Oct 1, 1992·Experimental Cell Research·T NordströmL C Andersson
Jan 3, 1990·Journal of the National Cancer Institute·E C Kohn, L A Liotta
Oct 15, 1990·The Biochemical Journal·J E MerrittT J Rink
Oct 1, 1994·Pflügers Archiv : European journal of physiology·D FranziusR Penner
Nov 1, 1994·British Journal of Pharmacology·S C ChungP Gardner
Nov 15, 1994·European Journal of Pharmacology·M GerickeB Nilius
Aug 23, 1996·Biochemical and Biophysical Research Communications·H WatanabeR Ohno
Oct 9, 1996·International Journal of Cancer. Journal International Du Cancer·W J WasilenkoP F Schellhammer
Apr 1, 1997·Journal of Neuro-oncology·W JacobsE C Kohn
Apr 24, 2001·Endocrinology·B D BennettK A Hruska
Jan 16, 2003·Biochemical Pharmacology·Jacquie L HarperJohn W Daly
Mar 1, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Terry W MoodyElise C Kohn
Apr 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jun IshikawaToshimitsu Yamada
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mahrukh M HussainElise C Kohn
Mar 27, 2004·American Journal of Physiology. Cell Physiology·Xiaoxia WangSteven C Sansom
Jun 4, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Man-Kyo ChungMichael J Caterina
Jun 15, 2004·The Journal of Biological Chemistry·Hong-Zhen HuMichael X Zhu
Nov 24, 2004·European Journal of Pharmacology·Damon PoburkoUrs T Ruegg
May 4, 2005·The Journal of Cell Biology·Jack RoosKenneth A Stauderman
Jun 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Walter M StadlerMark J Ratain
Jun 4, 2005·Molecular Pharmacology·Jean-Philippe LievremontJames W Putney
Jun 24, 2005·The Journal of Biological Chemistry·Tatiana K ZagranichnayaMitchel L Villereal
Jul 12, 2005·Current Biology : CB·Jen LiouTobias Meyer
Dec 13, 2005·The Journal of Physiology·Lucía NúñezCarlos Villalobos
Dec 17, 2005·Cell Calcium·Eva C SchwarzMarkus Hoth
Apr 26, 2006·The Journal of General Physiology·Mingjiang LiLixia Yue

❮ Previous
Next ❯

Citations

Nov 19, 2021·Drug Discovery Today·Suman PandaSubhrangsu Chatterjee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis